Clinical trial
Genetic Testing to Understand and Address Renal Disease Disparities Across the United States - Pharmacogenetic Substudy
NCT06748040 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genetic Testing to Understand and Address Renal Disease Disparities Across the United States - Pharmacogenetic Substudy
- Lead sponsor
- Duke University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 10, 2020
- Completion date
- May 17, 2024
- Enrollment
- 1,874 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney disease, hypertension